| AD | Active disease |
| ADA | Adenosine deaminase |
| ADCC | Antibody-dependent cell-mediated cytotoxicity |
| ATP | Adenosine triphosphate |
| CSPG4 | Chondroitin sulfate proteoglycan 4 |
| CTL | Cytotoxic T lymphocyte |
| DC | Dendritic cell |
| EC | Endothelial cell |
| EMT | Epithelial-mesenchymal transition |
| ESCC | Esophageal squamous cell carcinoma |
| EV | Extracellular vesicle |
| HNSCC | Head and neck squamous cell carcinoma |
| HPV | Human papilloma virus |
| LSCC | Laryngeal squamous cell carcinoma |
| MISEV | Minimal information for studies of extracellular vesicles |
| MVB | Multivesicular body |
| NED | Nonevident disease |
| Nef | Negative regulatory factor |
| NK | Natural killer |
| OSCC | Oral squamous cell carcinoma |
| PDT | Photodynamic therapy |
| ROC | Receiver operating characteristic |
| SEC | Size exclusion chromatography |
| siRNA | Short interfering RNA |
| TEM | Transmission electron microscopy |
| TEX | Tumor-derived exosomes |
| TME | Tumor microenvironment |
| Treg | Regulatory T cells |
| UICC | Union for International Cancer Control |
| 4NQO | 4-nitroquinoline 1-oxide |